DE3100191C2 - - Google Patents
Info
- Publication number
- DE3100191C2 DE3100191C2 DE3100191A DE3100191A DE3100191C2 DE 3100191 C2 DE3100191 C2 DE 3100191C2 DE 3100191 A DE3100191 A DE 3100191A DE 3100191 A DE3100191 A DE 3100191A DE 3100191 C2 DE3100191 C2 DE 3100191C2
- Authority
- DE
- Germany
- Prior art keywords
- tablet
- amount
- active ingredient
- preparation according
- milligrams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11143080A | 1980-01-11 | 1980-01-11 | |
| US06/194,453 US4308251A (en) | 1980-01-11 | 1980-10-17 | Controlled release formulations of orally-active medicaments |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE3100191A1 DE3100191A1 (de) | 1981-12-10 |
| DE3100191C2 true DE3100191C2 (US06653308-20031125-C00199.png) | 1988-09-01 |
Family
ID=26808896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19813100191 Granted DE3100191A1 (de) | 1980-01-11 | 1981-01-07 | Pharmazeutische zubereitung und verfahren zu ihrer herstellung |
Country Status (22)
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2496082A (en) * | 1947-05-24 | 1950-01-31 | Ashenfelter William | Scaffold structure |
| IT1144911B (it) * | 1981-03-19 | 1986-10-29 | Pharmatec Spa | Composizione farmaceutica a rilascio controllato contenente ibuprofen |
| JPS59227817A (ja) * | 1983-06-07 | 1984-12-21 | Toyo Jozo Co Ltd | 持続性経口用ブレデニン製剤 |
| JPH0662404B2 (ja) * | 1983-06-14 | 1994-08-17 | シンテックス・ファーマシユーテイカルズ・インターナシヨナル・リミテツド | 制御放出性ナプロキセンおよびナプロキセンナトリウム錠 |
| ZA836030B (en) * | 1983-08-16 | 1985-02-27 | Verex Lab | Constant order release solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions |
| ZA836031B (en) * | 1983-08-16 | 1985-02-27 | Verex Lab | Constant release rate solid dosage theophylline formulation |
| US5385738A (en) * | 1983-10-14 | 1995-01-31 | Sumitomo Pharmaceuticals Company, Ltd. | Sustained-release injection |
| US4855134A (en) * | 1983-10-14 | 1989-08-08 | Sumitomo Pharmaceuticals Company, Limited | Sustained-release preparation |
| US4774091A (en) * | 1983-10-14 | 1988-09-27 | Sumitomo Pharmaceuticals Company, Ltd. | Long-term sustained-release preparation |
| DE3486029T2 (de) * | 1983-10-14 | 1993-05-13 | Sumitomo Pharma | Ifn-praeparat mit verzoegerter abgabe fuer parentale verabreichung. |
| ES2054613T3 (es) * | 1985-12-27 | 1994-08-16 | Sumitomo Pharma | Un metodo para preparar una formulacion de liberacion mantenida. |
| GB8601204D0 (en) * | 1986-01-18 | 1986-02-19 | Boots Co Plc | Therapeutic agents |
| US4968508A (en) * | 1987-02-27 | 1990-11-06 | Eli Lilly And Company | Sustained release matrix |
| ZA881301B (en) * | 1987-02-27 | 1989-10-25 | Lilly Co Eli | Sustained release matrix formulations |
| AU6403196A (en) | 1995-06-30 | 1997-02-05 | Baylor University | Polyester/carboxylic acid composite materials |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2953497A (en) * | 1953-06-03 | 1960-09-20 | Howard A Press | Therapeutic tablets |
| NL128902C (US06653308-20031125-C00199.png) * | 1960-06-06 | |||
| US3577514A (en) * | 1968-06-10 | 1971-05-04 | Pfizer | Sustained release pharmaceutical tablets |
| US3773920A (en) * | 1971-07-14 | 1973-11-20 | Nikken Chemicals Co Ltd | Sustained release medicinal composition |
| US3906086A (en) * | 1971-07-19 | 1975-09-16 | Richard G Powers | Timed-release aspirin |
| GB1500300A (en) * | 1975-01-06 | 1978-02-08 | Ciba Geigy Ag | Pharmaceutical preparation for the treatment of circulatory disorders |
| JPS5411226A (en) * | 1977-06-24 | 1979-01-27 | Shin Etsu Chem Co Ltd | Disintegratable granule |
-
1980
- 1980-12-23 NZ NZ195933A patent/NZ195933A/xx unknown
- 1980-12-23 IN IN1418/CAL/80A patent/IN151913B/en unknown
-
1981
- 1981-01-05 AU AU65976/81A patent/AU542824B2/en not_active Ceased
- 1981-01-06 FR FR8100087A patent/FR2473308B1/fr not_active Expired
- 1981-01-07 NL NL8100037A patent/NL8100037A/nl not_active Application Discontinuation
- 1981-01-07 DE DE19813100191 patent/DE3100191A1/de active Granted
- 1981-01-08 CH CH9281A patent/CH646604A5/fr not_active IP Right Cessation
- 1981-01-08 JP JP157881A patent/JPS56103110A/ja active Pending
- 1981-01-08 DK DK6181A patent/DK6181A/da not_active Application Discontinuation
- 1981-01-08 BE BE0/203426A patent/BE886998A/fr unknown
- 1981-01-08 GB GB8100522A patent/GB2067072B/en not_active Expired
- 1981-01-08 ES ES498369A patent/ES8205353A1/es not_active Expired
- 1981-01-09 GR GR63828A patent/GR73843B/el unknown
- 1981-01-09 SE SE8100104A patent/SE447450B/sv not_active IP Right Cessation
- 1981-01-09 IT IT47537/81A patent/IT1221041B/it active
- 1981-01-09 CA CA000368219A patent/CA1140466A/en not_active Expired
- 1981-01-09 IE IE36/81A patent/IE50806B1/en unknown
- 1981-01-09 FI FI810056A patent/FI76927C/fi not_active IP Right Cessation
- 1981-01-09 NO NO810062A patent/NO156153C/no unknown
- 1981-01-09 AT AT0005481A patent/AT374681B/de not_active IP Right Cessation
- 1981-01-09 LU LU83052A patent/LU83052A1/fr unknown
- 1981-01-09 ZA ZA00810136A patent/ZA81136B/xx unknown
-
1982
- 1982-01-29 ES ES509179A patent/ES509179A0/es active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3100191C2 (US06653308-20031125-C00199.png) | ||
| DE2950977C2 (US06653308-20031125-C00199.png) | ||
| DE1617374C2 (de) | Verfahren zum Herstellen eines pharmazeutischen Präparates mit verzögerter analgetischer Wirkung | |
| AT394310B (de) | Verfahren zur herstellung lagerstabiler, schnellzerfallender pharmazeutischer wirkstoff-presslinge | |
| DE2224534C3 (de) | Pharmazeutisches Präparat mit langsamer Wirkstoffabgabe | |
| DE69233328T3 (de) | Oxycodonhaltige Arzneizusammensetzungen mit verzögerter Wirkstoffabgabe | |
| DE3329265C2 (US06653308-20031125-C00199.png) | ||
| DE69829042T2 (de) | Nicotinsäurezusammensetzungen enthaltender Starterkit | |
| DE2604044C2 (de) | Verfahren zur Herstellung von oral verabreichbaren, keinen bitteren Geschmack aufweisenden, Midecamycin als bitteren Wirkstoff enthaltenden Arzneimitteln | |
| DE60207951T2 (de) | Pharmazeutische Formulierungen von Thyroidhormonen | |
| EP0250648B1 (de) | Pharmazeutisches Präparat zur verzögerten Freigabe von Ibuprofen | |
| EP0469328B1 (de) | Verfahren zur Herstellung klein dimensionierter Formkörper mit hohem Etofibrat-Gehalt und kontrollierter Wirkstoff-Freisetzung, deren Verwendung und daraus bestehende oral verabreichbare Applikationsformen | |
| DE19820801A1 (de) | Orale Arzneiformen mit reproduzierbarer Wirkstofffreisetzung von Gatifloxacin oder pharmazeutisch verwendbaren Salzen oder Hydraten | |
| DE2718260C2 (de) | Verfahren zur Herstellung einer therapeutischen Zusammensetzung | |
| EP0146863A2 (de) | Orale retardierte Acetylsalicylsäureformulierungen | |
| EP1469835B1 (de) | Stabile salze von o-acetylsalicylsäure mit basischen aminosäuren ii | |
| EP0164571B1 (de) | Retardformen des alpha-(2,5-Dimethoxy-phenyl)-beta-lycinamido-äthanols und Verfahren zu ihrer Herstellung | |
| DE3609005A1 (de) | Pharmazeutische zusammensetzungen mit metabolischer aktivitaet | |
| DE2760284C2 (US06653308-20031125-C00199.png) | ||
| DE2424950A1 (de) | Pharmazeutische allopurinol-enthaltende zubereitungen und verfahren zu ihrer herstellung | |
| DE3942131A1 (de) | Zusammensetzung auf der basis von trimebutin mit verlaengerter wirkstoff-freisetzung und verfahren zu deren herstellung | |
| DE2404257C3 (de) | Verfahren zur Herstellung von Arzneimittelgranulaten mit Depotwirkung | |
| DE2415490C3 (de) | Überzugsmittel für feste Arzneimittel | |
| WO2005115404A1 (de) | Kombination von salzen der o-acetylsalicylsäure und alpha-glucosidase-inhibitoren | |
| DE3616054C2 (US06653308-20031125-C00199.png) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8127 | New person/name/address of the applicant |
Owner name: THE BOOTS CO. PLC, NOTTINGHAM, GB |
|
| 8128 | New person/name/address of the agent |
Representative=s name: SCHWABE, H., DIPL.-ING. SANDMAIR, K., DIPL.-CHEM. |
|
| 8110 | Request for examination paragraph 44 | ||
| D2 | Grant after examination | ||
| 8363 | Opposition against the patent | ||
| 8331 | Complete revocation |